ZVRA
Ticker
Zevra Therapeutics, Inc.
ZVRA · Healthcare · Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United St…Zevra Therapeutics, Inc. (ZVRA), in the Healthcare sector, has 6 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 0 purchases and 6 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Aug 14 and filed Aug 17. The most active filer was Neil F. McFarlane with 4 filings.
Add to watchlistFilings, ttm
6
0 buys · 6 sells
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$2.2M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Aug 14
Filed Aug 17
ADViAverage daily dollar volume
$19.3M
market data
Share price · 12M
$11.65 (+46.5%)
Adjusted for splits and dividends.
Volume by month
Buys $158K
Sells $3.2M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
NMRecent filings
Rahsaan ThompsonSALE
Chief Legal & Compliance
$475K42,666 sh × $11.13
Exec Aug 14
Filed Aug 17 · 4:32 PM ET Corey Michael WattonSALE Director $138K
12,300 sh × $11.25
Exec Aug 10
Filed Aug 12 · 4:16 PM ET Rahsaan ThompsonSALE Chief Legal & Compliance $438K
34,557 sh × $12.68
Exec Jun 22
Filed Jun 23 · 5:30 PM ET Neil F. McFarlaneSALE President and CEO $125K
14,625 sh × $8.56
Exec Feb 9
Filed Feb 10 · 5:30 PM ET Neil F. McFarlaneSALE President and CEO $854K
91,000 sh × $9.38
Exec Feb 2
Filed Feb 2 · 5:30 PM ET Neil F. McFarlaneSALE President and CEO $211K
19,500 sh × $10.82
Exec Oct 10 2025
Filed Oct 10 2025 · 5:30 PM ET Alvin ShihPURCHASE Director $158K
20,000 sh × $7.89
Exec Sep 12 2025
Filed Sep 15 2025 · 4:07 PM ET Rahsaan ThompsonSALE Chief Legal & Compliance $221K
24,000 sh × $9.21
Exec Jun 26 2025
Filed Jun 30 2025 · 5:30 PM ET Neil F. McFarlaneSALE President and CEO $727K
91,817 sh across 2 lots
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET